Focus area: Vaccines

• 

  An interview with Professor Nicola Stonehouse

  Nicola Stonehouse is a Professor in Molecular Virology at the University of Leeds and a member of the Microbiology Society. In this interview she tells us more about her area of research, how vaccination has had an enormous impact on human and animal health, and how her lab has adopted a new strategy to produce candidate vaccines.

• 

  An interview with Dr Othmar Engelhardt

  Dr Othmar Engelhardt is a Principal Scientist in the Influenza Resource Centre of the National Institute for Biological Standards and Control (NIBSC). He is also a member of the Microbiology Society and, in this interview tells us more about how his research contributes to vaccine production.

• 

  An interview with Professor Brendan Wren

  Brendan Wren is Professor of Microbial Pathogenesis at the London School of Hygiene and Tropical Medicine. His research group focuses on bacterial glycosylation and the use of glycoengineering for vaccine production.

• 

  An interview with Professor Jeffrey Almond

  Professor Jeffrey Almond is Chairman of the Scientific Advisory Board at Osivax. His expertise lies within vaccination and Influenza. His research majorly contributed to the understanding of polio and how to eradicate the virus via vaccination.

• 

  An interview with Dr Clare Jolly

  Dr Clare Jolly is an Associate Professor in Virus Cell Biology at University College London and a member of the Microbiology Society. Her lab researches the cell biology of HIV-1 infection and its spread in T cells, to inform future antiviral strategies. In this interview, she tells us more about her research and explains why it is so important to undertake infection research.

• 

  An interview with Professor Roberto La Ragione

  Professor Roberto La Ragione is Director of the Veterinary Pathology Centre and Head of the Department of Pathology and Infectious Diseases at the University of Surrey. Roberto’s research group is interested in understanding the mechanisms of how bacterial pathogens colonise the host.

• 

  An interview with Professor Simon Foster

  Simon Foster is a Professor of Molecular Microbiology and the Faculty Director of Research and Innovation at the University of Sheffield. He is also a member of the Microbiology Society, and in this interview, he tells us more about how his lab works to understand Staphylococcus aureus as an antimicrobial-resistant pathogen, phagocyte interactions and how this research has led to drive the development of a vaccine.

• 

  An interview with Dr Lee Sherry

  Dr Lee Sherry is a Postdoctoral Researcher in molecular virology at the University of Leeds and a member of the Microbiology Society. His research looks at the ways of producing next-generation virus-like particle vaccines, and in this interview, he tells us more about how his research is helping to eradicate disease and why microbiology matters.

• 

  An interview with Dr Norman Fry

  In this interview, Dr Norman Fry tells us about his role as a Clinical Scientist for Public Health England's National Infection Service and the battle with preventing the spread of Bordetella pertussis. Dr Fry also shares how his career developed over the years and why it is important to be involved with the Society.

• 

  An interview with Dr Karen Buttigieg

  Karen Buttigieg is a Senior Project Team Leader at Public Health England and a member of the Microbiology Society. In this interview, she tells us about her own views on testing new vaccines, why she thinks prevention is better than cure and why microbiology matters.

• 

  An interview with Dr Prerna Vohra

  Dr Prerna Vohra is a lecturer in Microbiology at the University of Edinburgh and a member of the Microbiology Society. In this interview, she tells us more about her research on Salmonella, why better understanding bacterial infections are important, and why microbiology matters.

• 

  An interview with Dr Andrew Bosworth

  Dr Andrew Bosworth is currently training to become a Clinical Scientist and is based at the University Hospitals Birmingham NHS Foundation Trust, Public Health England and the Bart’s School of Medicine and Dentistry in London. He is a member of the Microbiology Society and in this interview, tells us more about his research on the Makona variant of Ebola virus.

• 

  An interview with Dr Paul Klenerman

  Dr Paul Klenerman is an honorary consultant in microbiology at the University of Oxford, and a member of the Microbiology Society. In this interview he tells us more about his research on mucosal-associated invariant T cells and how this could impact disease eradication.

• 

  An interview with Dr Hadrien Peyret

  Dr Hadrien Peyret is a postdoctoral researcher at the John Innes Centre, and a member of the Microbiology Society. In this interview, he talks about developing plant-based pharmaceuticals and why he thinks vaccines are such an important output of microbiology research.

• 

  An interview with Professor Stephen Inglis

  Stephen Inglis is Honorary Professor, Division of Infection and Immunity, University College London and was previously Director of the National Institute for Biological Standards and Control (NIBSC). He is a member of the Microbiology Society and in this interview, he tells us more about his research, including how he has worked to ensure that vaccines are safe and effective for people around the world.

• 

  An interview with Dr Sam Stephen

  Dr Sam Stephen studied recombinant viral medicine at the Universities of Kerala, Oxford and Cologne on and carried out his postdoctoral research at University College London (UCL) and the University of Leeds. He is currently viral vectors senior scientist at the Centre for Process Innovation (CPI). Alongside collaborating authors, Dr Ruth Stephen (Affirm Medical Communications) and Dr Jonathan Welsh (AstraZeneca), they discuss why microbiology is essential to vaccine development.

• 

  An interview with Richard Urbanowicz

  Richard Urbanowicz is a Senior Virology Research Fellow at the University of Nottingham and a member of the Microbiology Society. In this interview he tells us about his research on the impact of host and virus genetic variation and working to identify the best vaccine candidates and evaluating their performance.

• 

  An interview with Professor Martin Ryan

  Professor Martin Ryan is based at the University of St Andrews, Scotland. He is a member of the Microbiology Society and was awarded the Unilever Colworth Prize in 2017 for his work on the 2A protein co-expression system. In this interview he tells us more about his research to date and how he is collaborating with other institutions to develop a vaccine for foot-and-mouth disease.

• 

  An interview with Vera Unwin

  Vera Unwin is a PhD student at the Liverpool School of Tropical Medicine and a member of the Microbiology Society. In this interview, she tells why her research is providing perspective into the transmission cycle of malaria and many other mosquito borne diseases and why she thinks microbiology matters.

• 

  An interview with Dr Lucy Van Dorp

  Dr Lucy van Dorp is a computational geneticist based at University College London. She is a member of the Microbiology Society and in this interview, tells us more about her research, which uses population genetics, phylogenetics and machine learning methods to infer the key biological factors which contribute to emergence, spread and transmission of pathogens.

• 

  An interview with Dr Odile Harrison

  Dr Odile Harrison is a Departmental Lecturer at the School of Zoology at the University of Oxford, UK and a member of the Microbiology Society. In this interview, she tells us more about her research, including the projects she has been involved in to try and help eradicate emerging diseases and exploring population the genomics of bacterial pathogens.